Alimera Sciences Inc (ALIM)
3.65
+0.17
(+4.89%)
USD |
NASDAQ |
May 03, 16:00
3.65
0.00 (0.00%)
After-Hours: 20:00
Alimera Sciences Revenue (Quarterly): 26.31M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.31M |
| September 30, 2023 | 23.36M |
| June 30, 2023 | 17.54M |
| March 31, 2023 | 13.55M |
| December 31, 2022 | 14.03M |
| September 30, 2022 | 13.60M |
| June 30, 2022 | 14.60M |
| March 31, 2022 | 11.90M |
| December 31, 2021 | 13.96M |
| September 30, 2021 | 12.15M |
| June 30, 2021 | 21.70M |
| March 31, 2021 | 11.21M |
| December 31, 2020 | 13.77M |
| September 30, 2020 | 12.47M |
| June 30, 2020 | 10.04M |
| March 31, 2020 | 14.54M |
| December 31, 2019 | 17.35M |
| September 30, 2019 | 12.85M |
| June 30, 2019 | 10.86M |
| March 31, 2019 | 12.89M |
| December 31, 2018 | 15.12M |
| September 30, 2018 | 11.14M |
| Date | Value |
|---|---|
| June 30, 2018 | 10.72M |
| March 31, 2018 | 9.63M |
| December 31, 2017 | 9.142M |
| September 30, 2017 | 9.784M |
| June 30, 2017 | 10.37M |
| March 31, 2017 | 6.618M |
| December 31, 2016 | 10.68M |
| September 30, 2016 | 8.298M |
| June 30, 2016 | 9.557M |
| March 31, 2016 | 5.801M |
| December 31, 2015 | 5.823M |
| September 30, 2015 | 6.901M |
| June 30, 2015 | 5.776M |
| March 31, 2015 | 3.938M |
| December 31, 2014 | 1.741M |
| September 30, 2014 | 2.408M |
| June 30, 2014 | 2.19M |
| March 31, 2014 | 2.084M |
| December 31, 2013 | 0.935M |
| September 30, 2013 | 0.758M |
| June 30, 2013 | 0.179M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
10.04M
Minimum
Jun 2020
26.31M
Maximum
Dec 2023
15.04M
Average
13.77M
Median
Dec 2020
Revenue (Quarterly) Benchmarks
| Eli Lilly and Co | 8.768B |
| NovaBay Pharmaceuticals Inc | 3.727M |
| Palatin Technologies Inc | 2.034M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.781M |
| Total Expenses (Quarterly) | 25.58M |
| EPS Diluted (Quarterly) | -0.0722 |
| Enterprise Value | 243.52M |
| Gross Profit Margin (Quarterly) | 86.22% |
| Profit Margin (Quarterly) | -14.37% |
| Earnings Yield | -59.24% |
| Normalized Earnings Yield | -39.63 |